Argun Akcakanat (A Akcakanat)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Risk

Tyrosine Kinase

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery 14 (5) (2024)
Timothy P DiPeri, Kurt W Evans, Bailiang Wang, Ming Zhao, Argun Akcakanat, Maria Gabriela Raso, Yasmeen Q Rizvi, Xiaofeng Zheng, Anil Korkut, Kaushik Varadarajan, Burak Uzunparmak, Ecaterina E Ileana Dumbrava, Shubham Pant, Jaffer A Ajani, Paula R Pohlmann, Vanessa B Jensen, Milind M Javle, Jordi Rodon Ahnert, Funda Meric-Bernstam
Co-Clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer discovery (2024)
S-U Woo, T Sangai, Argun Akcakanat, H Chen, C Wei, F Meric-Bernstam
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer. Oncogenesis 6 (10) (2017)